Horizon Technology Finance Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HRZN research report →
Range $4.5 – $5.5
Price Chart
About the company
Horizon Technology Finance Corporation operates as a business development company (BDC) with a core focus on providing financing and making equity investments in businesses in their early growth phases. The firm primarily offers secured debt and venture loans to companies that have already secured funding from venture capital firms. Its investment interests span various industries, including technology, life sciences, healthcare information and services, and clean technology.
- CEO
- Michael Phillip Balkin
- IPO
- 2010
- HQ
- Farmington, CT, US
Get TickerSpark's AI analysis on HRZN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $204.85M
- P/E
- -4.28
- Fwd P/E
- 4.56
- PEG
- 0.00
- P/S
- 2.24
- P/B
- 0.58
- EV/EBITDA
- -17.40
- Div Yield
- 33.12%
- Gross Margin
- 79.70%
- Op Margin
- 61.79%
- Net Margin
- -58.45%
- ROE
- -15.05%
- ROIC
- 7.32%
Latest fiscal year · YoY change
- Revenue
- $40.02M+17.9%
- Gross Profit
- $7.22M+327.9%
- Op Income
- $-1,598,000
- Net Income
- $-2,661,000+52.8%
- EPS
- $-0.06+60.8%
- OCF Growth
- +42.9%
- FCF Growth
- +42.9%
- 52W High
- $6.78
- 52W Low
- $2.94
- 50D MA
- $4.24
- 200D MA
- $4.57
- Beta
- 0.98
- RSI (14)
- 23
- Avg Volume
- 567.60K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Horizon grew its portfolio and pipeline in Q3, but NAV remained under pressure from stressed credits even as NII covered the dividend.· November 5, 2026
- Backlog rose to $351 million, up more than $42 million from Q2, and management said it is the strongest pipeline they have had in quite a while.
- The debt investment portfolio grew for a fourth straight quarter to $650 million after funding 9 investments totaling $98 million.
- Net investment income was $0.19 per share, covering the regular distribution, while NAV per share fell to $5.56 from $6.23 in Q2.
- Credit issues remain a central overhang: NAV declined $0.67 quarter over quarter mainly from write-downs on stressed investments, which management said are mostly in nonaccrual.
- The board declared monthly distributions of $0.06 per share for January, February and March 2027, supported by $0.24 per share of undistributed spillover income.
Third-quarter investment income was $24.1 million, down from $26.3 million in the prior-year period. Net investment income was $0.19 per share versus $0.11 per share in Q2 2026 and $0.32 per share in Q3 2025. NAV per share ended at $5.56, down from $6.23 in Q2 and $7.12 a year ago. The debt portfolio yield was 14.7% for the quarter, and onboarding yield was 12.6%. Available liquidity was $211 million, including $108 million of cash and $103 million of available borrowing base capacity. Looking ahead, management said it expects a lower level of prepayments in Q4, but still expects portfolio growth to be a little above the roughly $30 million average seen over the last three quarters, though not significantly above that. The board declared monthly distributions of $0.06 per share for January, February and March 2027.
Mike Balkin emphasized that Horizon is building a larger pipeline and backlog, with the company laying the foundation for long-term portfolio growth and higher NII. He highlighted the addition of Manuel Henriquez as Chief Growth and Strategy Officer and said the firm is benefiting from Monroe Capital’s backing and the team’s execution. His tone was upbeat on growth prospects, but he acknowledged that NAV remains under stress from credit pressures and said the company is working through those issues, with improvement expected to become more apparent in 2027.
Daniel Trolio focused on the balance sheet and earnings mechanics. He said Horizon had $211 million of available liquidity at September 30, no borrowings on the $150 million KeyBank facility, $181 million outstanding on the $250 million New York Life facility, and $90 million outstanding on the $150 million Nuveen facility, with potential new investment capacity of $387 million and net leverage at 0.82:1 versus a debt-to-equity ratio of 1.12:1. He also noted the adviser waived $1 million of base management fee in the quarter, total expenses were $12.5 million, and the company repurchased just over 2 million shares at an average price of $4.90. He said 98% of the portfolio should benefit from further increases in the pricing index because nearly all debt investments are floating rate.
Analysts pressed management on the stressed credits and whether the turnaround processes were near-term stabilizations or longer efforts. Paul Seitz said the majority, if not all, of the stressed names are in nonaccrual, that the team is working aggressively to recover value, and that he did not want to give forward-looking detail on timing. Questions also focused on the elevated prepayments and how quickly the larger backlog could convert into funded loans; management said prepayments should normalize somewhat in Q4 and that the pipeline typically works on a rolling six-month basis. On the Manuel Henriquez hire, Mike Balkin said his experience from Hercules is helping on origination and relationships, and that Horizon expects to benefit from his background as it works to execute its strategy.
The company is seeing stronger originations and backlog growth, with management calling the pipeline the strongest in a long time and saying it positions Horizon to grow materially in Q4 and beyond. NII covered the distribution, liquidity was ample, leverage remained below target, and the portfolio yield remained near the top of the BDC industry at 14.7%.
NAV fell sharply again, and management said stressed credits and write-downs were the main driver, with some names on nonaccrual and recovery timelines still uncertain. Investment income was lower than a year ago, and management cautioned that the credit issues are not fully resolved even though they believe progress will become more apparent in 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.5%
- Shares Outstanding
- 65.13M
- Float Shares
- 64.78M
of shares held by institutions
113 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bulldog Investors, Llp | 658.62K | ▲ 658.62K |
| Caprock Group, LLC | 454.44K | ▲ 454.44K |
| Green Alpha Advisors, LLC | 386.78K | ▼ 43.13K |
| Legal & General Group PLC | 386.21K | ▲ 57.56K |
| Eagle Point Credit Management LLC | 363.54K | ▼ 2.65K |
| Ubs Group AG | 261.92K | ▲ 66.45K |
| Blackrock, Inc. | 236.83K | ▲ 55.93K |
| Bank Of America Corp | 225.73K | ▲ 164.78K |
| Connecticut Wealth Management, LLC | 215.52K | ▲ 1.01K |
| Blair William & Co/Il | 202.49K | ▼ 36.58K |
| Virtus Investment Advisers, LLC | 183.43K | ▼ 69.02K |
| Arax Advisory Partners | 129.31K | ▲ 3.00K |
Held by 9 ETFs
Biggest fund positions in HRZN by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | ALLISON THOMAS J. | buy | 6,000 |
| Jun 9, 26 | O'Connor Kimberley Ann | buy | 10,000 |
| Jun 9, 26 | Goodman Jonathan Joseph | buy | 6,000 |
| Jun 10, 26 | Trolio Daniel R. | buy | 11,500 |
| Jun 9, 26 | Seitz Paul G | buy | 11,477 |
| Jun 9, 26 | ALLISON THOMAS J. | buy | 6,000 |
| Jun 9, 26 | Balkin Michael | buy | 100,000 |
| Apr 14, 26 | ALLISON THOMAS J. | other | 49,926 |
| Apr 14, 26 | Seitz Paul G | other | 142 |
| Apr 14, 26 | Balkin Michael | other | 93,527 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our HRZN coverage
Recent articles, reports, and earnings notes.
No research on HRZN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HRZN report →Down 16.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Horizon Technology Finance (HRZN)
zacks.com · Nov 17
4 High-Yield Dividend Stocks With Ex-Dates Approaching. One Yields 43.6%
247wallst.com · Nov 13
Are Investors Undervaluing Horizon Technology Finance (HRZN) Right Now?
zacks.com · Nov 12
Horizon Technology Finance Q3 Earnings Call Highlights
marketbeat.com · Nov 6
Horizon Technology Finance (HRZN) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 5
Horizon Technology Finance (HRZN) Q3 Earnings Match Estimates
zacks.com · Nov 5
Horizon Technology Finance Announces Monthly Distributions for January, February and March 2027 Totaling $0.18 per Share
businesswire.com · Nov 5
Horizon Technology Finance Announces Third Quarter 2026 Financial Results
businesswire.com · Nov 5
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.